Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Cardiovascular efficacy and safety of bococizumab in high-risk patients
Internal Medicine
Radiology
Cardiovascular Research Priority Area
Research output
:
Contribution to journal
›
Article
›
peer-review
435
Citations (SciVal)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cardiovascular efficacy and safety of bococizumab in high-risk patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Patient
100%
Placebo
100%
Low Density Lipoprotein Cholesterol
50%
Cardiovascular System
40%
Follow up
30%
Hazard Ratio
30%
Development
20%
Proprotein Convertase 9
20%
Cardiovascular Disease
10%
Combination Therapy
10%
Cardiovascular Risk
10%
Antibody
10%
Inpatient
10%
Apoplexy
10%
Myocardial Infarction
10%
Monoclonal Antibody
10%
Unstable Angina Pectoris
10%
Revascularization
10%
Injection Site Reaction
10%
Pharmacology, Toxicology and Pharmaceutical Science
Bococizumab
100%
Low Density Lipoprotein Cholesterol
50%
Proprotein Convertase 9
20%
Cardiovascular Disease
10%
Antibody
10%
Death
10%
Statin (Protein)
10%
Heart Infarction
10%
Cardiovascular Risk
10%
Unstable Angina Pectoris
10%
Monoclonal Antibody
10%
Injection Site Reaction
10%